Status:
COMPLETED
Non-invasive BCI for Cognitive Enhancement
Lead Sponsor:
University of Texas at Austin
Conditions:
Healthy Subjects
Neuropsychiatric Disorders
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
People's perceptual skills can significantly affect their abilities to make optimal decisions, judgments, and actions in real-world dynamic environments. Perceptual learning refers to training and exp...
Eligibility Criteria
Inclusion
- Able-bodied volunteers:
- good general health
- normal or corrected vision
- no history of neurological/psychiatric disease
- ability to read and understand English
- ability to understand information and ability to give a free and informed consent
- Subjects with neuropsychiatric diseases
- Subjects with neuropsychiatric diseases such as bipolar disorder and schizophrenia.
- normal or corrected vision
- ability to read and understand English
- ability to understand information and ability to give a free and informed consent
Exclusion
- short attentional spans or cognitive deficits that prevent to remain concentrated during the experimental sessions
- concomitant serious illnesses (e.g., metabolic disorders, cardiac arrest)
- factors hindering proper EEG acquisition (e.g., scalp wound, uncontrolled muscle activity)
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2023
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT05311878
Start Date
January 1 2021
End Date
November 1 2023
Last Update
April 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Engineering Education and Research Center
Austin, Texas, United States, 78712